Hayashi R, Ishikawa Y, Katayama T, Quantock A, Nishida K. CD200 facilitates the isolation of corneal epithelial cells derived from human pluripotent stem cells. Sci Rep. 2018;8:16550 pubmed publisher

Tamaoki N, Siebert S, Maeda T, Ha N, Good M, Huang Y, et al. Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells. Cell Rep Methods. 2023;3:100460 pubmed publisher

Hua Y, Yoshimochi K, Li J, Takekita K, Shimotsuma M, Li L, et al. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells. Stem Cell Res Ther. 2022;13:223 pubmed publisher

Shimoda Y, Murakoshi N, Mori H, Xu D, Tajiri K, Hemmi Y, et al. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation. Stem Cell Res. 2022;62:102793 pubmed publisher

Zhao M, Chi F, Zhang T, Teng X, Li K. Human menstrual blood-derived mesenchymal stem cells regulation of the EGF/Ras p21 pathway as a potential therapeutic target for thin endometrium. Ann Transl Med. 2021;9:1476 pubmed publisher

Dor L, Rabinski T, Zlotnik D, Shilian M, Weil M, Vatine G. Induced pluripotent stem cell (iPSC) lines from two individuals carrying a homozygous (BGUi007-A) and a heterozygous (BGUi006-A) mutation in ELP1 for in vitro modeling of familial dysautonomia. Stem Cell Res. 2021;55:102495 pubmed publisher

Klaihmon P, Luanpitpong S, Lorthongpanich C, Laowtammathron C, Waeteekul S, Terbto P, et al. Episomal vector reprogramming of human umbilical cord blood natural killer cells to an induced pluripotent stem cell line MUSIi013-A. Stem Cell Res. 2021;55:102472 pubmed publisher

Beylina A, Langston R, Rosen D, Reed X, Cookson M. Generation of fourteen isogenic cell lines for Parkinson's disease-associated leucine-rich repeat kinase (LRRK2). Stem Cell Res. 2021;53:102354 pubmed publisher

Nomi K, Hayashi R, Ishikawa Y, Kobayashi Y, Katayama T, Quantock A, et al. Generation of functional conjunctival epithelium, including goblet cells, from human iPSCs. Cell Rep. 2021;34:108715 pubmed publisher

Wang Y, Hu G, Hill R, Dzieciatkowska M, Hansen K, Zhang X, et al. Matrix reverses immortalization-mediated stem cell fate determination. Biomaterials. 2021;265:120387 pubmed publisher

Kimura Y, Tanaka Y, Shirasu N, Yasunaga S, Higurashi N, Hirose S. Establishment of human induced pluripotent stem cells derived from skin cells of a patient with Dravet syndrome. Stem Cell Res. 2020;47:101857 pubmed publisher

Bi Y, Tu Z, Zhang Y, Yang P, Guo M, Zhu X, et al. Identification of ALPPL2 as a Naive Pluripotent State-Specific Surface Protein Essential for Human Naive Pluripotency Regulation. Cell Rep. 2020;30:3917-3931.e5 pubmed publisher

Pan C, Lang H, Zhang T, Wang R, Lin X, Shi P, et al. Conditioned medium derived from human amniotic stem cells delays H2O2‑induced premature senescence in human dermal fibroblasts. Int J Mol Med. 2019;44:1629-1640 pubmed publisher

Wei X, Sun G, Zhao X, Wu Q, Chen L, Xu Y, et al. Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response. Int J Mol Med. 2019;: pubmed publisher

Shibata S, Hayashi R, Okubo T, Kudo Y, Katayama T, Ishikawa Y, et al. Selective Laminin-Directed Differentiation of Human Induced Pluripotent Stem Cells into Distinct Ocular Lineages. Cell Rep. 2018;25:1668-1679.e5 pubmed publisher

Tanaka Y, Higurashi N, Shirasu N, Yasunaga S, Moreira K, Okano H, et al. Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene. Stem Cell Res. 2018;31:11-15 pubmed publisher

Tanaka Y, Sone T, Higurashi N, Sakuma T, Suzuki S, Ishikawa M, et al. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene. Stem Cell Res. 2018;28:100-104 pubmed publisher

Wang G, Zhao F, Yang D, Wang J, Qiu L, Pang X. Human amniotic epithelial cells regulate osteoblast differentiation through the secretion of TGF?1 and microRNA-34a-5p. Int J Mol Med. 2017;: pubmed publisher

Garcia Montero A, Jara Acevedo M, Alvarez Twose I, Teodosio C, Sanchez Muñoz L, Muñiz C, et al. KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression. Blood. 2016;127:761-8 pubmed publisher

Zheng Y, Thomas A, Schmidt C, Dann C. Quantitative detection of human spermatogonia for optimization of spermatogonial stem cell culture. Hum Reprod. 2014;29:2497-511 pubmed publisher

Chung K, Kolling F, Gajdosik M, Burger S, Russell A, Nelson C. Single cell analysis reveals the stochastic phase of reprogramming to pluripotency is an ordered probabilistic process. PLoS ONE. 2014;9:e95304 pubmed publisher

Niwa A, Heike T, Umeda K, Oshima K, Kato I, Sakai H, et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS ONE. 2011;6:e22261 pubmed publisher